Abstract:Background: Kaempferol (Kae) is a natural flavonol compound with excellent anti-inflammatory and immunomodulatory effects, which is of great importance in the treatment of inflammatory diseases. The efficacy of Kae in the treatment of rheumatoid arthritis (RA) has been demonstrated. However, its relevant pharmacodynamic mechanism requires further investigation. Purposes: This study aimed to further explore the potential mechanism of action of Kae in the treatment of RA using network pharmacology, single-cell analysis, and animal experiments. Methods: Drug target genes were downloaded and screened from the Comparative Toxicogenomics Database (CTD), SwissTargetPrediction database, BindingDB database, and TargetNet database. Transcriptome data from GEO databases (GSE55235, GSE89408, and GSE200815) were selected for disease transcriptome analysis and single-cell matrix data. Network pharmacology and molecular docking were used to investigate the potential mechanism of action of Kae in treating RA. Single-cell analysis, immune infiltration co-expression analyses, and Mendelian-Randomization (MR) studies were conducted to explore the relationship between Kae's target genes and immune cells. Collagen-induced arthritis (CIA) was induced in DBA/1 mouse models through enhanced immunization. Therapeutic efficacy of Kae was assessed using arthritis score, paw swelling index, body weight monitoring, microCT, hematoxylin and eosin (HE) staining, Safranin O-Fast green staining, and Tartrate-resistant acid phosphatase (TRAP) staining. Tissue immunofluorescence and flow cytometry were used to detect expression levels of key genes and immune cell activation status. Results: In vivo experiments demonstrated the efficacy of Kae in treating CIA mice. Network pharmacology indicated that Kae might exert anti-inflammatory effects through the NLRP3/CASP1/GSDMD axis. Immune infiltration, single-cell, and MR analyses revealed close associations between Kae's target genes and CD4+, CD8+, and regulatory T cells. Kae inhibited cellular pyroptosis in joint tissues and down-regulated NLRP3, CASP1, and GSDMD expression. Flow cytometry results showed decreased CD4/CD8 ratio, reduced proportion of CD4+ effector memory T cells (Tem), and increased naïve and regulatory T cells (Treg). Conclusion: Kae might exert anti-inflammatory effects by modulating the NLRP3/CASP1/GSDMD axis to inhibit pyroptosis and suppress overactive immune responses by regulating T-cell proliferation. In summary, Kae demonstrated significant therapeutic efficacy in treating RA.

Kaempferol: A New Immunosuppressant of Calcineurin

Studies on the interactions of kaempferol to calcineurin by spectroscopic methods and docking.

Quercetin Targets the Interaction of Calcineurin with LxVP-type Motifs in Immunosuppression.

Inhibition of Calcineurin by Quercetin in Vitro and in Jurkat Cells.

Quercitrin: a New Immunosuppressant Inhibits Calcineurin*

Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.

Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model

Quercetin Binds To Calcineurin At A Similar Region To Cyclosporin A And Tacrolimus

Kaempferol attenuates cyclosporine-induced renal tubular injury via inhibiting the ROS-ASK1-MAPK pathway

Kaempferol-3-O-glucorhamnoside Inhibits Inflammatory Responses Via MAPK and NF-κB Pathways in Vitro and in Vivo.

Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS

Inhibitory Effect of Kaempferol on Protein Kinase CK2 in vitro and in HL-60 Cells

Kaempferol attenuates carbon tetrachloride (CCl 4 )-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS

[Effects of Kaempferol and Quercetin on Cytochrome 450 Activities in Primarily Cultured Rat Hepatocytes].

The Regulatory Domains of Cna Have Different Effects on the Inhibition of Cn Activity by Fk506 and Csa

[Kaempferol Activates Human Steroid and Xenobiotic Receptor-Mediated Cytochrome P450 3A4 Transcription].

Isogarcinol Is A New Immunosuppressant

Cooperative autoinhibition and multi-level activation mechanisms of calcineurin

Study of kaempferol in the treatment of rheumatoid arthritis through modulation of the NLRP3/CASP1/GSDMD axis and T-cell activation: Based on network pharmacology, single-cell analysis, and experimental validation

Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1

Effect of Different Immunosuppressive Drugs on Calcineurin and Its Mutants